Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
To evaluate the safety and efficacy of Dextenza intracanalicular insert in patients with ocular graft-versus-host disease (GVHD).
Epistemonikos ID: 1b43586f48dbbf057cc2623f45e295d4d2d9e1cc
First added on: Dec 20, 2022